Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
about
Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsTh17 cytokines and vaccine-induced immunity.Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patientsIL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.The WSX-1 pathway restrains intestinal T-cell immunityA eukaryotic expression plasmid carrying chicken interleukin-18 enhances the response to newcastle disease virus vaccine.Prediction of T-cell epitopes of hepatitis C virus genotype 5aExpression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]..Local expression of interleukin-27 ameliorates collagen-induced arthritisNew IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.Maintenance of CMV-specific CD8+ T cell responses and the relationship of IL-27 to IFN-γ levels with aging.Smart adjuvants.Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.Interleukin 27: a double-edged sword for offense and defense.A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes.Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27.Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents.Type I interferons as regulators of human antigen presenting cell functions.Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.IL-23 gene therapy for mouse bladder tumour cell lines.The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.Influenza virus evades innate and adaptive immunity via the NS1 protein.Regulation and Immune Function of IL-27.T-bet is required for protection against vaccinia virus infection.Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant.Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice.The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia.
P2860
Q24675683-3BF301A9-944B-473B-855A-51C6E05048C9Q33792227-63949264-FBE8-40C8-9C06-E9286CD749A3Q33988140-DBC8E845-5020-4A11-8959-6D48899A1C7AQ34064081-FB1598F9-4935-4E82-85FF-1DEBE969A0E8Q34300986-2980ECE6-5574-430F-ADDC-7066785757BDQ34538706-10C83400-C994-4158-873F-6E00850A0174Q34785006-83C6DFBF-D495-4D4F-BE19-1D16E4994F76Q34896702-1FFC8342-83B9-4E88-941A-DC643D406E9BQ35018373-84DBC36F-CF94-4839-87DB-1DBE8127D2B9Q35046582-A7AE5E29-7A9E-47B2-9497-E90F2F89C9A4Q36184396-75987A13-8534-4056-8068-3E50CE8C4DB5Q36585832-FB1B3E82-7774-471D-9EEC-9936482C71F4Q36837149-E874F6C8-0ED6-4FDB-A06D-168132BAAEA3Q37580862-ACF5FA12-556A-4F46-BAA8-779BFCB3E05CQ37607910-D841A230-4CB1-472D-A8C6-6CDB1778A301Q37747078-87E1CAF1-56E0-458F-8EE7-AC7D1690F34BQ37795583-AF4897D1-26E1-459D-95D1-DA19E049A3FAQ38191014-EA3598F4-3032-4142-8ADE-7CAAB3ED9C98Q38215320-812AA807-B619-4E69-B179-33859CD1A1E7Q38850577-797ADEB7-245A-4E1D-BBC7-B52C711BD885Q39571263-28F7F5F0-9BEE-45AF-B628-FE767674D966Q39796152-52DCA704-C1FC-43A2-9C02-0DA32449CCDBQ40267847-C99CFEC7-4387-484F-90E4-AAA9BDD20E2BQ40508641-A1E3F930-74C1-435F-B44A-9C7615C1F650Q42094910-5C2CDE88-BCB5-40AD-B8CB-83960468A94EQ42208607-F8B131DA-B8A6-4199-9A95-14C2E1DA45B8Q42223120-D2775A3F-D024-45AC-9624-A4B718FEBB24Q44509047-5FCAB5E9-3BA0-4EA3-A603-0DE2A0BCE755Q45362711-C74E7DB3-FBEC-4211-B60E-8FF5590E6CC1Q48118861-C434D324-80D7-4EE6-9C14-A99F199E3993
P2860
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@en
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@nl
type
label
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@en
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@nl
prefLabel
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@en
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice.
@nl
P2093
P2860
P921
P1433
P1476
Adjuvant activities of novel c ...... in HLA-A*0201 transgenic mice
@en
P2093
François A Lemonnier
Masanori Matsui
Osamu Moriya
Sadahiro Kamiya
Takayuki Yoshimoto
Toshitaka Akatsuka
P2860
P304
P356
10.1128/JVI.78.17.9093-9104.2004
P407
P577
2004-09-01T00:00:00Z